Relationship Between Time in Range and Dusk Phenomenon in Outpatients with Type 2 Diabetes Mellitus

References

• Yapanis M, James S, Craig ME, O’Neal D, Ekinci EI. Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring. J Clin Endocrinol Metab. 2022;107(6):e2221–e2236. doi:10.1210/clinem/dgac034
   PubMed Web of Science ®Google Scholar
• Klimontov VV, Semenova JF. Glucose variability in subjects with normal glucose tolerance: relations with body composition, insulin secretion and sensitivity. Diabetes Metab Syndr. 2022;16(1):102387. doi:10.1016/j.dsx.2022.102387
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang J, Liu L, et al. Significant abnormal glycemic variability increased the risk for arrhythmias in elderly type 2 diabetic patients. BMC Endocr Disord. 2021;21(1):83. doi:10.1186/s12902-021-00753-2
   PubMed Web of Science ®Google Scholar
• Rodbard D. Glucose variability: a review of clinical applications and research developments. Diabetes Technol Ther. 2018;20(S2):S25–S215. doi:10.1089/dia.2018.0092
   PubMedGoogle Scholar
• Schmidt MI, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski A. The Dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care. 1981;4(6):579–585. doi:10.2337/diacare.4.6.579
   PubMed Web of Science ®Google Scholar
• Rybicka M, Krysiak R, Okopień B. The Dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia. Endokrynol Pol. 2011;62(3):276–284.
   PubMed Web of Science ®Google Scholar
• Bolli GB, Gerich JE. The “Dawn phenomenon”--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med. 1984;310(12):746–750. doi:10.1056/nejm198403223101203
   PubMed Web of Science ®Google Scholar
• Li W, Du SN, Shi MJ, Sun ZZ. Spontaneous and transient predinner hyperglycemia in some patients with diabetes: dusk phenomenon. Medicine. 2016;95(47):e5440. doi:10.1097/md.0000000000005440
   PubMed Web of Science ®Google Scholar
• Du S, Shi MJ, Sun ZZ, Li W. Clinical diagnosis for dusk phenomenon of diabetes. Medicine. 2018;97(34):e11873. doi:10.1097/md.0000000000011873
   PubMed Web of Science ®Google Scholar
• Mian Z, Hermayer KL, Jenkins A. Continuous glucose monitoring: review of an innovation in diabetes management. Am J Med Sci. 2019;358(5):332–339. doi:10.1016/j.amjms.2019.07.003
   PubMed Web of Science ®Google Scholar
• Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254–2263. doi:10.1016/s0140-6736(16)31535-5
   PubMed Web of Science ®Google Scholar
• Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464–1476. doi:10.1056/NEJMoa0805017
   PubMed Web of Science ®Google Scholar
• Bao S, Bailey R, Calhoun P, Beck RW. Effectiveness of continuous glucose monitoring in older adults with type 2 diabetes treated with basal insulin. Diabetes Technol Ther. 2021;24(5):299–306. doi:10.1089/dia.2021.0494
   PubMed Web of Science ®Google Scholar
• Aleppo G, Beck RW, Bailey R, et al. The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. Diabetes Care. 2021;44(12):2729–2737. doi:10.2337/dc21-1304
   PubMedGoogle Scholar
• Monnier L, Colette C, Sardinoux M, Baptista G, Regnier-Zerbib A, Owens D. Frequency and severity of the Dawn phenomenon in type 2 diabetes: relationship to age. Diabetes Care. 2012;35(12):2597–2599. doi:10.2337/dc12-0385
   PubMed Web of Science ®Google Scholar
• Monnier L, Colette C, Dejager S, Owens D. Magnitude of the Dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care. 2013;36(12):4057–4062. doi:10.2337/dc12-2127
   PubMed Web of Science ®Google Scholar
• Huang Y, Xu Y, Qiu J, et al. The impact of dusk phenomenon on total glucose exposure in Chinese people with type 2 diabetes. Medicine. 2021;100(13):e25298. doi:10.1097/md.0000000000025298
   PubMed Web of Science ®Google Scholar
• Wang JS, Lee IT, Lee WJ, et al. The Dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs. Ther Adv Chronic Dis. 2021;12:20406223211033674. doi:10.1177/20406223211033674
   Web of Science ®Google Scholar
• O’Neal TB, Luther EE. Dawn Phenomenon. In: StatPearls. StatPearls PublishingCopyright © 2022, StatPearls Publishing LLC; 2022.
   Google Scholar
• Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabetes Res Clin Pract. 2005;69(1):14–21. doi:10.1016/j.diabres.2004.11.005
   PubMed Web of Science ®Google Scholar
• Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–1603. doi:10.2337/dci19-0028
   PubMed Web of Science ®Google Scholar
• Advani A. Positioning time in range in diabetes management. Diabetologia. 2020;63(2):242–252. doi:10.1007/s00125-019-05027-0
   PubMed Web of Science ®Google Scholar
• Runge AS, Kennedy L, Brown AS, et al. Does time-in-range matter? Perspectives from people with diabetes on the success of current therapies and the drivers of improved outcomes. Clin Diabetes. 2018;36(2):112–119. doi:10.2337/cd17-0094
   PubMedGoogle Scholar
• Agiostratidou G, Anhalt H, Ball D, et al. Standardizing clinically meaningful outcome measures beyond HbA(1c) for Type 1 diabetes: a consensus report of the american association of clinical endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. 2017;40(12):1622–1630. doi:10.2337/dc17-1624
   PubMed Web of Science ®Google Scholar
• Valenzano M, Cibrario Bertolotti I, Valenzano A, Grassi G. Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study. BMJ Open Diabetes Res Care. 2021;9(1):e001045. doi:10.1136/bmjdrc-2019-001045
   PubMed Web of Science ®Google Scholar
• Shah VN, Snell-Bergeon JK, Demmitt JK, et al. Relationship between time-in-range, HbA1c, and the glucose management indicator in pregnancies complicated by type 1 diabetes. Diabetes Technol Ther. 2021;23(12):783–790. doi:10.1089/dia.2021.0093
   PubMed Web of Science ®Google Scholar
• Sakai T, Aoyama K, Inazumi K, et al. Time in range correlates glycated albumin measured immediately after 2 weeks of continuous glucose monitoring. J Diabetes Complications. 2021;35(8):107962. doi:10.1016/j.jdiacomp.2021.107962
   PubMed Web of Science ®Google Scholar
• Ohigashi M, Osugi K, Kusunoki Y, et al. Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol. J Diabetes Investig. 2021;12(6):940–949. doi:10.1111/jdi.13437
   PubMed Web of Science ®Google Scholar
• Vigersky RA, McMahon C. The relationship of hemoglobin A1C to time-in-range in patients with diabetes. Diabetes Technol Ther. 2019;21(2):81–85. doi:10.1089/dia.2018.0310
   PubMed Web of Science ®Google Scholar
• Peng HM, Deng HR, Zhou YW, et al. 血糖变异性对1型糖尿病患者葡萄糖目标范围内时间与血糖管理指标关系的影响 [Impacts of glycemic variability on the relationship between time in range and estimated glycated hemoglobin in patients with type 1 diabetes mellitus]. Zhonghua Yi Xue Za Zhi. 2022;102(16):1190–1195. Chinese. doi:10.3760/cma.j.cn112137-20211009-02236
   PubMedGoogle Scholar
• Tokutsu A, Okada Y, Torimoto K, Tanaka Y. Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study. Diabetol Metab Syndr. 2020;12:70. doi:10.1186/s13098-020-00577-5
   PubMed Web of Science ®Google Scholar
• Piona C, Marigliano M, Mozzillo E, et al. High glycemic variability is associated with worse continuous glucose monitoring metrics in children and adolescents with type 1 diabetes. Horm Res Paediatr. 2021;94(9–10):369–373. doi:10.1159/000521430
   PubMed Web of Science ®Google Scholar
• Lu J, Ma X, Zhou J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care. 2018;41(11):2370–2376. doi:10.2337/dc18-1131
   PubMed Web of Science ®Google Scholar
• Yang J, Yang X, Zhao D, Wang X, Wei W, Yuan H. Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy. J Diabetes Investig. 2021;12(5):828–836. doi:10.1111/jdi.13394
   PubMed Web of Science ®Google Scholar
• Li F, Zhang Y, Li H, et al. TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes. Diabetes Res Clin Pract. 2020;166:108289. doi:10.1016/j.diabres.2020.108289
   PubMed Web of Science ®Google Scholar
• Yin X, Zhu W, Liu C, et al. Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation. Ther Adv Endocrinol Metab. 2022;13:20420188221099337. doi:10.1177/20420188221099337
   Web of Science ®Google Scholar
• Xie P, Deng B, Zhang X, et al. Time in range in relation to amputation and all-cause mortality in hospitalised patients with diabetic foot ulcers. Diabetes Metab Res Rev. 2022;38(2):e3498. doi:10.1002/dmrr.3498
   PubMed Web of Science ®Google Scholar
• Lu J, Ma X, Shen Y, et al. Time in range is associated with carotid intima-media thickness in type 2 diabetes. Diabetes Technol Ther. 2020;22(2):72–78. doi:10.1089/dia.2019.0251
   PubMed Web of Science ®Google Scholar
• Shen Y, Wang C, Wang Y, et al. Association between time in range and cancer mortality among patients with type 2 diabetes: a prospective cohort study. Chin Med J. 2021;135(3):288–294. doi:10.1097/cm9.0000000000001740
   PubMed Web of Science ®Google Scholar